Molecular pathogenesis of Waldenström's macroglobulinemia

Esteban Braggio, Casey Philipsborn, Anne Novak, Lucy Hodge, Stephen Ansell, Rafael Fonseca

Research output: Contribution to journalReview articlepeer-review

19 Scopus citations


Waldenström's macroglobulinemia is an indolent, lymphoproliferative disease, characterized by a heterogeneous lymphoplasmacytic bone marrow infiltrate and high immunoglobulin M production. While technological advances over the past several decades have dramatically improved the possibilities of studying the molecular basis of Waldenström's macroglobulinemia, the pathogenesis of the disease remains fragmented. Undoubtedly, research has been successful in uncovering underlying aberrations and deregulated mechanisms in this disease, providing useful information for identifying biomarkers for disease diagnosis, risk stratification and therapeutic intervention, but there is still a long way to go before the pathogenesis of Waldenström's macroglobulinemia is fully revealed. In addition, the low number of in vitro or in vivomodels significantly challenges extensive analysis. In this manuscript, we review the molecular basis of this disease.

Original languageEnglish (US)
Pages (from-to)1281-1290
Number of pages10
Issue number9
StatePublished - Sep 1 2012


  • IL-6
  • Jak/STAT
  • PI3K/Akt
  • WM, NF-kB signaling pathway
  • aCGH

ASJC Scopus subject areas

  • Hematology


Dive into the research topics of 'Molecular pathogenesis of Waldenström's macroglobulinemia'. Together they form a unique fingerprint.

Cite this